The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

7 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Synthesis and structure elucidation of novel fused 1,2,4-triazine derivatives as potent inhibitors targeting CYP1A1 activity.EBI
King Abdulaziz University
Recent developments of gallic acid derivatives and their hybrids in medicinal chemistry: A review.EBI
King Abdulaziz University
Structure-based development of novel triazoles and related thiazolotriazoles as anticancer agents and Cdc25A/B phosphatase inhibitors. Synthesis, in vitro biological evaluation, molecular docking and in silico ADME-T studies.EBI
King Abdulaziz University
Therapeutic methods and combinationsBDB
Individual
3-hydroxy-quinazoline-2,4-dione derivatives and their use as nuclease modulatorsBDB
Ludwig Institute For Cancer Research
Tetrahydroindazoles and medical uses thereofBDB
Genase Therapeutics
Synthesis and biological evaluation of thienopyrrolizines, a new family of CDK/GSK-3 inhibitors.BDB
UniversitÉ